Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Masoud ST"'
Publikováno v:
Current Medical Research & Opinion; Nov2008, Vol. 24 Issue 11, p3223-3237, 15p
Publikováno v:
In Value in Health 2008 11(3):A128-A128
Autor:
Xia D; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Lianoglou S; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Sandmann T; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Calvert M; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Suh JH; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Thomsen E; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Dugas J; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Pizzo ME; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., DeVos SL; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Earr TK; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Lin CC; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Davis S; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Ha C; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Leung AW; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Nguyen H; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Chau R; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Yulyaningsih E; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Lopez I; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Solanoy H; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Masoud ST; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Liang CC; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Lin K; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Astarita G; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Khoury N; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Zuchero JY; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Thorne RG; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA.; Department of Pharmaceutics, University of Minnesota, 9-177 Weaver-Densford Hall, 308 Harvard St. SE, Minneapolis, MN, 55455, USA., Shen K; Gladstone Institute of Neurological Disease, San Francisco, CA, 94158, USA.; Department of Neurology, University of California, San Francisco, CA, 94158, USA., Miller S; Gladstone Institute of Neurological Disease, San Francisco, CA, 94158, USA.; Department of Neurology, University of California, San Francisco, CA, 94158, USA., Palop JJ; Gladstone Institute of Neurological Disease, San Francisco, CA, 94158, USA.; Department of Neurology, University of California, San Francisco, CA, 94158, USA., Garceau D; The Jackson Lab, Bar Harbor, Maine, USA., Sasner M; The Jackson Lab, Bar Harbor, Maine, USA., Whitesell JD; Allen Institute for Brain Science, Seattle, Washington, USA., Harris JA; Allen Institute for Brain Science, Seattle, Washington, USA., Hummel S; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany., Gnörich J; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany., Wind K; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany., Kunze L; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany., Zatcepin A; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany., Brendel M; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany., Willem M; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany., Haass C; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig- Maximilians-Universität, München, 81377, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), 81377, Munich, Germany., Barnett D; Appel Alzheimer's Disease Research Institute, Weill Cornell Medicine, New York, NY, USA.; Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.; Neuroscience Graduate Program, Weill Cornell Medicine, New York, NY, USA., Zimmer TS; Appel Alzheimer's Disease Research Institute, Weill Cornell Medicine, New York, NY, USA.; Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA., Orr AG; Appel Alzheimer's Disease Research Institute, Weill Cornell Medicine, New York, NY, USA.; Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.; Neuroscience Graduate Program, Weill Cornell Medicine, New York, NY, USA., Scearce-Levie K; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Lewcock JW; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Di Paolo G; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Sanchez PE; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA. sanchez@dnli.com.
Publikováno v:
Molecular neurodegeneration [Mol Neurodegener] 2022 Jun 11; Vol. 17 (1), pp. 41. Date of Electronic Publication: 2022 Jun 11.
Autor:
Jennings D; Denali Therapeutics Inc., South San Francisco, CA, USA., Huntwork-Rodriguez S; Denali Therapeutics Inc., South San Francisco, CA, USA., Henry AG; Denali Therapeutics Inc., South San Francisco, CA, USA., Sasaki JC; Denali Therapeutics Inc., South San Francisco, CA, USA., Meisner R; Denali Therapeutics Inc., South San Francisco, CA, USA., Diaz D; Denali Therapeutics Inc., South San Francisco, CA, USA., Solanoy H; Denali Therapeutics Inc., South San Francisco, CA, USA., Wang X; Denali Therapeutics Inc., South San Francisco, CA, USA., Negrou E; Denali Therapeutics Inc., South San Francisco, CA, USA., Bondar VV; REGENXBIO, Rockville, MD, USA., Ghosh R; Denali Therapeutics Inc., South San Francisco, CA, USA., Maloney MT; Denali Therapeutics Inc., South San Francisco, CA, USA., Propson NE; Denali Therapeutics Inc., South San Francisco, CA, USA., Zhu Y; Denali Therapeutics Inc., South San Francisco, CA, USA., Maciuca RD; Denali Therapeutics Inc., South San Francisco, CA, USA., Harris L; Denali Therapeutics Inc., South San Francisco, CA, USA., Kay A; Denali Therapeutics Inc., South San Francisco, CA, USA., LeWitt P; Henry Ford Health System, Detroit, MI, USA., King TA; Covance, Dallas, TX, USA., Kern D; University of Colorado, School of Medicine, Aurora, CO, USA., Ellenbogen A; Michigan Institute for Neurological Disorders, Farmington Hills, MI, USA., Goodman I; Bioclinica Research, Orlando, FL, USA., Siderowf A; University of Pennsylvania, Penn Neurology Pennsylvania Hospital, Philadelphia, PA, USA., Aldred J; Inland Northwest Research, Spokane, WA, USA., Omidvar O; Collaborative Neuroscience Research, Long Beach, CA, USA., Masoud ST; Denali Therapeutics Inc., South San Francisco, CA, USA., Davis SS; Denali Therapeutics Inc., South San Francisco, CA, USA., Arguello A; Denali Therapeutics Inc., South San Francisco, CA, USA., Estrada AA; Denali Therapeutics Inc., South San Francisco, CA, USA., de Vicente J; Denali Therapeutics Inc., South San Francisco, CA, USA., Sweeney ZK; Interline Therapeutics, South San Francisco, CA, USA., Astarita G; Denali Therapeutics Inc., South San Francisco, CA, USA.; Henry Ford Health System, Detroit, MI, USA., Borin MT; Denali Therapeutics Inc., South San Francisco, CA, USA., Wong BK; Denali Therapeutics Inc., South San Francisco, CA, USA., Wong H; University of British Columbia, Vancouver, BC, Canada., Nguyen H; Denali Therapeutics Inc., South San Francisco, CA, USA., Scearce-Levie K; Denali Therapeutics Inc., South San Francisco, CA, USA., Ho C; Denali Therapeutics Inc., South San Francisco, CA, USA., Troyer MD; Denali Therapeutics Inc., South San Francisco, CA, USA.
Publikováno v:
Science translational medicine [Sci Transl Med] 2022 Jun 08; Vol. 14 (648), pp. eabj2658. Date of Electronic Publication: 2022 Jun 08.
Autor:
Vecchio LM; Department of Pharmacology and Toxicology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada., Sullivan P; Autonomic Medicine Section, Clinical Neurosciences Program, Division of Intramural Research, National Institute of Neurological, Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA., Dunn AR; The Jackson Laboratory. Bar Harbor, Maine, USA., Bermejo MK; Department of Pharmacology and Toxicology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada., Fu R; Department of Pharmacology, Emory University School of Medicine, Atlanta, GA, USA., Masoud ST; Department of Pharmacology and Toxicology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada., Gregersen E; Danish Research Institute of Translational Neuroscience - DANDRITE, Department of Biomedicine, Faculty of Health, Aarhus University, Aarhus C., Denmark., Urs NM; Department of Pharmacology and Therapeutics, University of Florida, Gainsville, FL, USA., Nazari R; Department of Pharmacology and Toxicology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada., Jensen PH; Danish Research Institute of Translational Neuroscience - DANDRITE, Department of Biomedicine, Faculty of Health, Aarhus University, Aarhus C., Denmark., Ramsey A; Department of Pharmacology and Toxicology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada., Goldstein DS; Autonomic Medicine Section, Clinical Neurosciences Program, Division of Intramural Research, National Institute of Neurological, Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA., Miller GW; Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University Medical Centre, New York, NY, USA., Salahpour A; Department of Pharmacology and Toxicology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Publikováno v:
Journal of neurochemistry [J Neurochem] 2021 Aug; Vol. 158 (4), pp. 960-979. Date of Electronic Publication: 2021 Jun 12.
Autor:
Lohr KM; Department of Environmental Health, Rollins School of Public Health, Emory University, 1518 Clifton Road, Atlanta, GA, 30322, USA., Masoud ST; Department of Pharmacology and Toxicology, University of Toronto, ON, Canada., Salahpour A; Department of Pharmacology and Toxicology, University of Toronto, ON, Canada., Miller GW; Department of Environmental Health, Rollins School of Public Health, Emory University, 1518 Clifton Road, Atlanta, GA, 30322, USA.; Center for Neurodegenerative Diseases, Emory University, Atlanta, GA, USA.; Department of Pharmacology, Emory University, Atlanta, GA, USA.; Department of Neurology, Emory University, Atlanta, GA, USA.
Publikováno v:
The European journal of neuroscience [Eur J Neurosci] 2017 Jan; Vol. 45 (1), pp. 20-33. Date of Electronic Publication: 2016 Sep 02.
Autor:
Trossbach SV; Department Neuropathology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Bader V; Department Neuropathology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Hecher L; Department Neuropathology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Pum ME; Center for Behavioral Neuroscience, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Masoud ST; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada., Prikulis I; Department Neuropathology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Schäble S; Center for Behavioral Neuroscience, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., de Souza Silva MA; Center for Behavioral Neuroscience, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Su P; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada., Boulat B; Functional Architecture of Memory Unit, Mercator Research Group, Faculty of Medicine, Ruhr University Bochum, Bochum, Germany., Chwiesko C; Functional Architecture of Memory Unit, Mercator Research Group, Faculty of Medicine, Ruhr University Bochum, Bochum, Germany., Poschmann G; Molecular Proteomics Laboratory, BMFZ, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Stühler K; Molecular Proteomics Laboratory, BMFZ, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Lohr KM; Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA., Stout KA; Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA., Oskamp A; Institute of Neuroscience and Medicine, INM-2, Forschungszentrum Jülich, Jülich, Germany., Godsave SF; The Netherlands Cancer Institute, Amsterdam, The Netherlands., Müller-Schiffmann A; Department Neuropathology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Bilzer T; Department Neuropathology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Steiner H; Department of Cellular and Molecular Pharmacology, The Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA., Peters PJ; The Netherlands Cancer Institute, Amsterdam, The Netherlands., Bauer A; Institute of Neuroscience and Medicine, INM-2, Forschungszentrum Jülich, Jülich, Germany., Sauvage M; Functional Architecture of Memory Unit, Mercator Research Group, Faculty of Medicine, Ruhr University Bochum, Bochum, Germany., Ramsey AJ; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada., Miller GW; Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA., Liu F; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada., Seeman P; Departments of Pharmacology and Psychiatry, University of Toronto, Toronto, Ontario, Canada., Brandon NJ; AstraZeneca Neuroscience iMED, Cambridge, MA, USA., Huston JP; Center for Behavioral Neuroscience, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Korth C; Department Neuropathology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Publikováno v:
Molecular psychiatry [Mol Psychiatry] 2016 Nov; Vol. 21 (11), pp. 1561-1572. Date of Electronic Publication: 2016 Jan 12.
Autor:
Masoud ST; Department of Pharmacology and Toxicology, University of Toronto, 1 King's College Circle - Rm 4302, Toronto, ON M5S 1A8, Canada. Electronic address: shababa.masoud@mail.utoronto.ca., Vecchio LM; Department of Pharmacology and Toxicology, University of Toronto, 1 King's College Circle - Rm 4302, Toronto, ON M5S 1A8, Canada. Electronic address: laura.vecchio@mail.utoronto.ca., Bergeron Y; Department of Medical Biology, Université du Québec à Trois-Rivières, QC G9A 5H7 Canada. Electronic address: yan.bergeron@uqtr.ca., Hossain MM; Environmental and Occupational Health Sciences Institute, Rutgers, 170 Frelinghuysen Road, EOHSI 340, Piscataway, NJ 08854, USA. Electronic address: mhossain@eohsi.rutgers.edu., Nguyen LT; Department of Pharmacology and Toxicology, University of Toronto, 1 King's College Circle - Rm 4302, Toronto, ON M5S 1A8, Canada. Electronic address: Lien.nguyen@mail.utoronto.ca., Bermejo MK; Department of Pharmacology and Toxicology, University of Toronto, 1 King's College Circle - Rm 4302, Toronto, ON M5S 1A8, Canada. Electronic address: kristel.bermejo@mail.utoronto.ca., Kile B; Department of Chemistry, University of North Carolina at Chapel Hill, NC 27599, USA. Electronic address: bkile04@gmail.com., Sotnikova TD; Neuroscience and Brain Technologies, Italian Institute of Technology, Via Morego 30, Genova 16163, Italy; Faculty of Biology and Soil Science, St. Petersburg State University, St. Petersburg 199034, Russia. Electronic address: tatiana.sotnikova@iit.it., Siesser WB; Department of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA. Electronic address: billsiesser@gmail.com., Gainetdinov RR; Neuroscience and Brain Technologies, Italian Institute of Technology, Via Morego 30, Genova 16163, Italy; Faculty of Biology and Soil Science, St. Petersburg State University, St. Petersburg 199034, Russia; Skolkovo Institute of Science and Technology, Skolkovo, 143025 Moscow Region, Russia. Electronic address: Raul.Gainetdinov@iit.it., Wightman RM; Department of Chemistry, University of North Carolina at Chapel Hill, NC 27599, USA. Electronic address: rmw@unc.edu., Caron MG; Department of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA. Electronic address: marc.caron@duke.edu., Richardson JR; Environmental and Occupational Health Sciences Institute, Rutgers, 170 Frelinghuysen Road, EOHSI 340, Piscataway, NJ 08854, USA. Electronic address: jricha3@eohsi.rutgers.edu., Miller GW; Department of Environmental Health, Emory University, Atlanta, GA 30322, USA; Department of Pharmacology, Emory University, Atlanta, GA 30322, USA; Department of Neurology, Emory University, Atlanta, GA 30322, USA. Electronic address: gwmille@emory.edu., Ramsey AJ; Department of Pharmacology and Toxicology, University of Toronto, 1 King's College Circle - Rm 4302, Toronto, ON M5S 1A8, Canada. Electronic address: a.ramsey@utoronto.ca., Cyr M; Department of Medical Biology, Université du Québec à Trois-Rivières, QC G9A 5H7 Canada. Electronic address: Michel.Cyr@uqtr.ca., Salahpour A; Department of Pharmacology and Toxicology, University of Toronto, 1 King's College Circle - Rm 4302, Toronto, ON M5S 1A8, Canada. Electronic address: ali.salahpour@utoronto.ca.
Publikováno v:
Neurobiology of disease [Neurobiol Dis] 2015 Feb; Vol. 74, pp. 66-75. Date of Electronic Publication: 2014 Oct 30.
Autor:
Medvedev IO; Department of Cell Biology, Duke University Medical Center, Durham, North Carolina 27710, Department of Pharmacology and Toxicology, Faculty of Medicine, University of Toronto, Toronto, Ontario M5S 1A8, Canada, Department of Neuroscience and Brain Technologies, Istituto Italiano di Tecnologia, 16163 Genova, Italy, Skolkovo Institute of Science and Technology, Skolkovo, Moscow Region, 143025, Russia, Faculty of Biology and Soil Science, St. Petersburg State University, St. Petersburg 199034, Russia, and Department of Psychiatry and Neuroscience, Faculty of Medicine, Laval University and Institut Universitaire en Santé Mentale de Québec, Québec City, Québec G1J 2G3, Canada., Ramsey AJ, Masoud ST, Bermejo MK, Urs N, Sotnikova TD, Beaulieu JM, Gainetdinov RR, Salahpour A
Publikováno v:
The Journal of neuroscience : the official journal of the Society for Neuroscience [J Neurosci] 2013 Nov 13; Vol. 33 (46), pp. 18125-33.
Publikováno v:
International journal of geriatric psychiatry [Int J Geriatr Psychiatry] 2009 Oct; Vol. 24 (10), pp. 1174-6.